novel avenues for mm treatment: car t-cells, venetoclax, induction & mrd
Published 6 years ago • 57 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
1:59
novel car-t constructs being investigated for the treatment of all
-
1:34
cctx-001: a novel car-t therapy for aml
-
0:49
novel targets for car-t therapy in mcl
-
8:16
future avenues for car t-cell therapy in all
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma
-
1:12
novel all treatment strategies: car t-cells
-
2:49
novel strategies to optimize car-t therapy in myeloma
-
4:58
novel immunotherapies transforming r/r myeloma treatment: bispecifics, car-t cells & more
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
1:26
an insight into ctx130: a novel allogeneic car-t cell therapy
-
2:27
bms-986393, a novel anti-gprc5d car-t cell therapy, in multiple myeloma
-
2:45
car-t treatment outcomes: mm real-world data
-
3:10
universal car-t therapy for t-all
-
4:10
car t-cell therapy for all
-
2:57
the promise of allogeneic car-t cell products for the treatment of hematological malignancies
-
0:47
novel targets in car-t therapy for multiple myeloma: integrin beta-7 & cd98 heavy chain